Prof. John Gribben | ICML 2017 | Highlights of CLL

Anne Villeneuve

Natasha Fort

Jun 22, 2017

Highlights of CLL at ICML 2017

More about...

Anne Villeneuve Chronic lymphocytic leukemia ICML 2017 Monoclonal B-cell lymphocytosis Natasha Fort

SOHO 2019 | What are the novel prognostic factors for the treatment of patients with CLL?

At SOHO 2019, we spoke to Dr Alessandra Ferrajoli about novel prognostic factors and how they are used for the treatment of patients with chronic lymphocytic...

Sep 18, 2019

SOHO 2019 | What are the novel prognostic factors for the treatment of patients with CLL?

At SOHO 2019, we spoke to Dr Alessandra Ferrajoli about novel prognostic factors and how they are used for the...

Sep 18, 2019

Prevalence of BTK and PLCG2 mutations in a CLL cohort still on ibrutinib after three years

Anne Quinquenel conducted a study to investigate patients from the FILO study, who were still on ibrutinib after three years.

Aug 7, 2019

Prevalence of BTK and PLCG2 mutations in a CLL cohort still on ibrutinib after three years

Anne Quinquenel conducted a study to investigate patients from the FILO study, who were still on ibrutinib...

Aug 7, 2019

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month

First Name

Last Name

I agree to the Lymphoma Hub Terms & Conditions

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Prof. John Gribben | ICML 2017 | Highlights of CLL

Anne Villeneuve

Natasha Fort

Jun 22, 2017

More about...

Related articles

Sep 18, 2019

Sep 18, 2019

Aug 7, 2019

Aug 7, 2019

Newsletter